IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$67.00 USD
-4.21 (-5.91%)
Updated May 8, 2024 04:00 PM ET
After-Market: $66.99 -0.01 (-0.01%) 6:40 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.22 | 5.09% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.31 per share. This reflects a positive earnings surprise of 48.39%. Look out for ITCI's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year increase of 51.11%.
Earnings History
Price & Consensus
Zacks News for ITCI
Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services